Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / COM NEW
-
Number of holders
-
27
-
Total 13F shares, excl. options
-
3,037,215
-
Shares change
-
+178,515
-
Total reported value, excl. options
-
$929,392
-
Value change
-
+$57,233
-
Number of buys
-
11
-
Number of sells
-
-5
-
Price
-
$0.3060
Significant Holders of IGC Pharma, Inc. - COM NEW (IGC) as of Q2 2025
29 filings reported holding IGC - IGC Pharma, Inc. - COM NEW as of Q2 2025.
IGC Pharma, Inc. - COM NEW (IGC) has 27 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3,037,215 shares
.
Largest 10 shareholders include BlackRock, Inc. (703,798 shares), GEODE CAPITAL MANAGEMENT, LLC (703,303 shares), VANGUARD GROUP INC (645,166 shares), CITADEL ADVISORS LLC (270,966 shares), STATE STREET CORP (160,207 shares), NORTHERN TRUST CORP (113,407 shares), DEARBORN PARTNERS LLC (84,401 shares), GOLDMAN SACHS GROUP INC (65,541 shares), RENAISSANCE TECHNOLOGIES LLC (55,025 shares), and Virtu Financial LLC (46,892 shares).
This table shows the top 27 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.